S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.49
+1.81
+10.85%
SCYX · SCYNEXIS, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$3.84
+0.16
(+4.35%)
● At close: October 20 at 4:00:00 PM EDT
DAY'S RANGE
$3.84
$3.78
$3.84
52-WEEK RANGE
$3.84
$3.53
$9.12
What's happening
- SCYX is up 4.35% today, trading at $3.84. — Live quote
- Volume today (838) is well below its 3-month average of 225,700. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.63 actual vs. $-0.52 estimated (+221.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 5
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (9 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SCYX
-24.90%
vs S&P 500
-37.68%
1-YEAR RETURN
SCYX
-38.31%
vs S&P 500
-52.87%
6-MONTH RETURN
SCYX
-54.76%
3-MONTH RETURN
SCYX
-6.17%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.63
Est. $-0.52
BEAT +221.9%
2026-04-26 (Q1 2026)
$-3.36
Est. $-1.01
MISS -233.9%
2026-01-26 (Q4 2025)
$1.94
Est. $1.03
BEAT +87.3%
2025-10-26 (Q3 2025)
$-1.36
Est. $-1.63
BEAT +16.7%
Valuation Measures & Ratios
Enterprise Value4$27.3M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)1.97
Price / Book70.60
EV4 / Revenue1.42
EV4 / EBITDA0.37
Profit Margin57.58%
Operating Margin-29.45%
Return on Equity (ROE8)-21.10%
Return on Assets (ROA9)-15.58%
Avg Volume (3M)225,700
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $47.6M | $369.2M | $314.9M | $33.3M | $392.1M |
| P/E | -1.62 | -8.76 | -13.30 | -1.13 | -17.62 |
| Price/Sales | 24.63 | 188.84 | 120.43 | 11.02 | 129.57 |
| Price/Book | 0.71 | 8.94 | 8.64 | 0.75 | 7.76 |
| EV/Revenue | 19.21 | 170.08 | 114.78 | 7.37 | 127.27 |
| ROE | -43.89% | -102.08% | -64.99% | -66.44% | -44.02% |
| ROA | -39.19% | -54.32% | -46.36% | -48.67% | -32.76% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short594,318
Change from Prior Settlement+29.27%
% of Float—
Days to Cover (Short Ratio)1.00
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Net profit margin is 57.6%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-09-28; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -82.8% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is -38.3%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SCYX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $235.0K | $0 | $334.0K | $1.4M | $257.0K | $660.0K | $736.0K | $1.4M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$7.8M | -$16.9M | -$8.4M | -$9.6M | -$8.6M | -$10.3M | -$9.2M | -$9.5M |
| Net income | $7.4M | -$21.3M | -$8.6M | -$6.9M | -$5.4M | -$2.8M | -$14.5M | $411.0K |
| EPS (diluted) | $0.63 | $-0.42 | $-0.17 | $-1.11 | $-0.11 | $-0.06 | $-0.30 | $0.01 |
| EPS (basic) | $0.63 | $-0.42 | $-0.17 | $-1.11 | $-0.11 | $-0.06 | $-0.30 | $0.01 |
| Operating margin | -$3.3K | — | -$2.5K | -$701 | -$3.4K | -$1.6K | -$1.3K | -$692 |
| Net margin | $3.1K | — | -$2.6K | -$505 | -$2.1K | -$425 | -$2.0K | $30 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $75.0M | $77.6M | $59.0M | $51.1M | $60.7M | $67.9M | $90.6M | $99.0M |
| Total liabilities | $8.0M | $36.3M | $9.7M | $14.6M | $16.2M | $17.4M | $35.6M | $40.5M |
| Stockholders' equity | $66.9M | $41.3M | $49.4M | $36.4M | $44.5M | $50.5M | $55.1M | $58.5M |
| Total current assets | $56.2M | $62.7M | $40.4M | $48.7M | $56.5M | $52.2M | $72.2M | $80.5M |
| Total current liabilities | $5.8M | $15.9M | $5.7M | $8.5M | $10.9M | $9.0M | $24.1M | $25.7M |
| Cash & equivalents | $10.5M | $36.7M | $21.3M | $14.8M | $11.0M | $6.9M | $16.1M | $28.7M |
| Marketable securities (current) | $43.6M | $22.6M | $18.8M | $23.1M | $33.8M | $33.7M | $43.2M | $40.1M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Other current assets | $930.0K | $569.0K | $17.0K | $195.0K | $867.0K | $891.0K | $1.2M | $953.0K |
| Property, plant & equipment | — | — | — | — | — | — | — | — |
| Intangible assets | — | — | — | — | — | — | — | — |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Accounts payable | $3.3M | $5.6M | $2.2M | $3.5M | $6.2M | $4.3M | $4.6M | $5.0M |
| Accrued liabilities | $2.0M | $1.5M | $2.8M | $2.8M | $2.5M | $2.6M | $3.8M | $5.5M |
| Deferred revenue (current) | $0 | $235.0K | $235.0K | $1.8M | $1.8M | $1.6M | $1.6M | $1.6M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Retained earnings | -$399.0M | -$406.4M | -$385.1M | -$397.4M | -$388.8M | -$381.9M | -$376.5M | -$372.1M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$14.9M | -$8.1M | $18.4M | -$8.7M | -$7.5M | -$7.5M | -$9.9M | $765.0K |
| Investing cash flow | -$24.8M | -$525.0K | -$11.8M | $12.4M | $11.3M | $12.4M | -$2.6M | $1.9M |
| Financing cash flow | $13.5M | $24.0M | -$115.0K | $29.0K | $0 | -$14.1M | -$155.0K | $31.0K |
| Capital expenditures | — | — | — | — | — | — | — | — |
| Share-based compensation | $568.0K | $580.0K | $687.0K | $526.0K | $820.0K | $819.0K | $981.0K | $901.0K |
| Change in accounts receivable | — | — | — | — | — | — | $0 | $0 |
| Change in inventory | — | — | — | — | — | — | $0 | $0 |
| Change in accounts payable | -$472.0K | $906.0K | -$1.2M | -$2.7M | $1.9M | -$199.0K | -$484.0K | -$407.0K |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $20.6M | $3.7M | $140.1M | $5.1M | $13.2M |
| Gross profit | — | — | — | — | — |
| Operating income | -$16.1M | -$37.1M | $72.7M | -$85.8M | -$60.8M |
| Net income | -$8.6M | -$21.3M | $67.0M | -$62.8M | -$32.9M |
| EPS (diluted) | $-0.17 | $-0.44 | $1.39 | $-1.47 | $-1.25 |
| EPS (basic) | $-0.17 | $-0.44 | $1.40 | $-1.47 | $-1.25 |
| Operating margin | -$78 | -$991 | $52 | -$1.7K | -$462 |
| Net margin | -$42 | -$568 | $48 | -$1.2K | -$250 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $59.0M | $90.6M | $128.4M | $87.8M | $119.8M |
| Total liabilities | $9.7M | $35.6M | $55.5M | $84.6M | $78.6M |
| Stockholders' equity | $49.4M | $55.1M | $73.0M | $3.2M | $41.3M |
| Total current assets | $40.4M | $72.2M | $102.1M | $79.1M | $109.4M |
| Total current liabilities | $5.7M | $24.1M | $16.3M | $17.6M | $13.6M |
| Cash & equivalents | $21.3M | $16.1M | $34.0M | $45.8M | $104.5M |
| Marketable securities (current) | $18.8M | $43.2M | $40.3M | $27.7M | $0 |
| Accounts receivable | — | — | $0 | $2.1M | $861.0K |
| Inventory | — | — | $0 | $899.0K | $463.0K |
| Other current assets | $17.0K | $1.2M | $4.9M | $62.0K | $4.0K |
| Property, plant & equipment | — | — | — | — | $113.0K |
| Intangible assets | — | — | $0 | $408.0K | $1.1M |
| Other non-current assets | — | — | $0 | $5.5M | $6.2M |
| Accounts payable | $2.2M | $4.6M | $7.1M | $5.9M | $7.8M |
| Accrued liabilities | $2.8M | $3.8M | $7.5M | $5.6M | $5.7M |
| Deferred revenue (current) | $235.0K | $1.6M | $1.2M | $0 | — |
| Short-term debt | — | — | — | — | $0 |
| Other current liabilities | — | — | $0 | $5.8M | $0 |
| Long-term debt | — | — | — | — | $34.4M |
| Other non-current liabilities | — | — | — | $0 | $3.3M |
| Retained earnings | -$385.1M | -$376.5M | -$355.2M | -$422.3M | -$359.5M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$5.3M | -$24.0M | $60.2M | -$79.9M | -$54.6M |
| Investing cash flow | $24.3M | $6.2M | -$34.9M | -$27.4M | -$1.2M |
| Financing cash flow | -$14.2M | -$139.0K | -$36.7M | $48.6M | $67.1M |
| Free cash flow | — | — | — | — | -$54.6M |
| Capital expenditures | — | — | — | — | $0 |
| Share-based compensation | $2.9M | $3.3M | $2.6M | $3.7M | $2.1M |
| Change in accounts receivable | — | $0 | -$2.1M | $1.2M | $861.0K |
| Change in inventory | — | $0 | $8.8M | $436.0K | $5.3M |
| Change in accounts payable | -$2.2M | -$2.6M | $1.2M | -$1.5M | $2.8M |
| Debt repaid | — | — | — | — | — |
| Tax withholding on stock comp | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SCYX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-06-20 to 2026-09-18
Recent transactions
- Most recent: Burke Steven Keith (Reporting person) — Grant / award of 5,750 shares on 2026-09-18.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Burke Steven Keith | Reporting person | Grant / award | 2026-09-18 | 5,750 |
| Tinmouth Brian Philippe | Reporting person | Grant / award | 2026-06-26 | 2,875 |
| Macdonald Guy | Reporting person | Grant / award | 2026-06-26 | 2,875 |
| ANIDO ARMANDO | Reporting person | Grant / award | 2026-06-26 | 2,875 |
| HASTINGS DAVID C | Reporting person | Grant / award | 2026-06-26 | 2,875 |
| HANHAM ANN | Reporting person | Grant / award | 2026-06-26 | 2,875 |
| Angulo Gonzalez David | Chief Executive Officer | Open market purchase | 2026-04-01 | 108,695 |
| Macleod ivor | Chief Financial Officer | Grant / award | 2026-01-29 | 129,833 |
| Sukenick Scott | Chief Legal Officer | Grant / award | 2026-01-29 | 129,833 |
| GILMAN STEVEN C | Reporting person | Grant / award | 2025-06-26 | 23,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-18 | Burke Steven Keith | Reporting person | Grant / award | 5,750 | $0.00 |
| 2026-06-26 | Tinmouth Brian Philippe | Reporting person | Grant / award | 2,875 | $0.00 |
| 2026-06-26 | Macdonald Guy | Reporting person | Grant / award | 2,875 | $0.00 |
| 2026-06-26 | ANIDO ARMANDO | Reporting person | Grant / award | 2,875 | $0.00 |
| 2026-06-26 | HASTINGS DAVID C | Reporting person | Grant / award | 2,875 | $0.00 |
| 2026-06-26 | HANHAM ANN | Reporting person | Grant / award | 2,875 | $0.00 |
| 2026-04-01 | Angulo Gonzalez David | Chief Executive Officer | Open market purchase | 108,695 | — |
| 2026-01-29 | Macleod ivor | Chief Financial Officer | Grant / award | 129,833 | $0.00 |
| 2026-01-29 | Sukenick Scott | Chief Legal Officer | Grant / award | 129,833 | $0.00 |
| 2026-01-29 | Angulo Gonzalez David | Chief Executive Officer | Grant / award | 391,333 | $0.00 |
| 2025-10-17 | Angulo Gonzalez David | Chief Executive Officer | Grant / award | 32,500 | $0.76 |
| 2025-06-26 | Tinmouth Brian Philippe | Reporting person | Grant / award | 23,000 | $0.00 |
| 2025-06-26 | Macdonald Guy | Reporting person | Grant / award | 23,000 | $0.00 |
| 2025-06-26 | HASTINGS DAVID C | Reporting person | Grant / award | 23,000 | $0.00 |
| 2025-06-26 | HANHAM ANN | Reporting person | Grant / award | 23,000 | $0.00 |
| 2025-06-26 | GILMAN STEVEN C | Reporting person | Grant / award | 23,000 | $0.00 |
| 2025-06-26 | ANIDO ARMANDO | Reporting person | Grant / award | 23,000 | $0.00 |
| 2025-04-09 | Angulo Gonzalez David | Chief Executive Officer | Grant / award | 23,000 | $0.84 |
| 2025-03-20 | Angulo Gonzalez David | Chief Executive Officer | Grant / award | 13,800 | $1.05 |
| 2025-03-19 | Angulo Gonzalez David | Chief Executive Officer | Grant / award | 5,000 | $1.07 |
| 2025-01-23 | Sukenick Scott | Chief Legal Officer | Grant / award | 92,511 | $0.00 |
| 2025-01-23 | Macleod ivor | Chief Financial Officer | Grant / award | 92,511 | $0.00 |
| 2025-01-23 | Angulo Gonzalez David | Chief Executive Officer | Grant / award | 262,927 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:24 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-28 | 8-K | 2026-09-25 | View on SEC.gov → |
| 2026-09-22 | 4 | 2026-09-18 | View on SEC.gov → |
| 2026-09-22 | 8-K | 2026-09-18 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-09 | View on SEC.gov → |
| 2026-09-10 | 8-K | 2026-09-09 | View on SEC.gov → |
| 2026-08-10 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-26 | 8-K | 2026-06-25 | View on SEC.gov → |
Recent news
Headlines about SCYX (SCYNEXIS, Inc.). Links open the publisher — we don’t host full articles.
-
SCYNEXIS, Inc. (SCYX) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-22 -
SCYNEXIS to present antifungal drug SCY-247 at ...
Pluang · 2026-10-21 -
SCYNEXIS to Feature SCY-247 in a Pipeline Presentation at IDWeek
Yahoo · 2026-10-21 -
SCYNEXIS will present a candidate that may act against drug-resistant fungi
Stock Titan · 2026-10-21 -
SCYX Dec 2026 5.000 call (SCYX261218C00005000) interactive stock chart
Yahoo Finance UK · 2026-10-17 -
SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Yahoo Finance · 2026-10-06 -
Scynexis stock surges on $214M BARDA contract for SCY-247
Yahoo Finance · 2026-09-28 -
Scynexis Shares Rise 13.9% After BARDA Awards SCY-247 Development Contract
Yahoo Finance · 2026-09-28
No headlines in this category right now — try “All”.